11/21/2025Recent Executive Moves

11/21/2025NMPA Issues New Rules on Inspections and Export Certificates for Drug ...

11/21/2025CSPC Advances Nectin-4 ADC SYS6002 Into First Phase 3 Trial

11/21/2025RocRock Biotech Raises CNY 50M to Advance Next-Gen CAR-M Therapies

11/21/2025Lynk Reports Positive Phase II Results for Topical JAK Inhibitor

11/21/2025Xiangxue Expands Into In Vivo TCR-T Therapy Through New Partnership

11/21/2025Innovent Moves Toward China Filing After High-Dose Obesity Drug Delive...

11/20/2025Innovent's Mazdutide Achieves Strong Phase 3 Results in Chinese Obesit...

11/20/2025GSK, LTZ Forge Strategic Alliance to Advance Novel Myeloid Cell Engage...

11/20/2025NHC Issues the Guidelines for Strengthening Service Capacity in Primar...

11/20/2025China Pilots Next-Generation AI Reforms Across Public Hospitals

More>>

11/21/2025China's Biopharma Innovation Surges — McKinsey Lays Out Both Opportun...

11/21/2025US Report Flags Risks From China's Expanding Control of Pharma Supply ...

11/20/2025China Biopharma Tracker – October 2025 (PharmaDJ)

11/20/2025China's Innovation-drug BD Boom Slows as Investors Shift Focus to Prod...

11/18/2025China's October Approvals Signal the Next Five Years of Translational ...

11/18/2025China Biopharma Strikes Record USD 19.9 B in Licensing Deals in Octobe...

11/14/2025MNCs Face Diverging Fortunes and Strategic Reset in China

11/14/2025Review of China's Late-Stage Global Innovative Drug Pipeline in 2025

11/13/2025Innovative Antibody Therapeutic Development in China Compared with the...

11/5/2025China Wraps Up 2025 Drug Negotiation: Dual Catalogs Debut, Innovative ...

11/5/2025MNCs Retreat as China Cancels Dozens of Branded Medicines Amid Price C...

More>>